Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Construction of new manufacturing plant | 9.52 |
| 2 | Installation of Machinery | 5.52 |
| 3 | Working Capital Requirement | 13.45 |
| 4 | General corporate purposes | 3.52 |
| Total | 32.00 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Assets | 71.91 | 56.71 |
| Total Income | 82.05 | 47.06 |
| Profit After Tax | 3.30 | 4.16 |
| Amount in ₹ Crore | ||
JFL Life Sciences Limited is a pharmaceutical manufacturing company headquartered in Ahmedabad, Gujarat. The company specializes in producing a range of pharmaceutical formulations, including dry powder injections, tablets and capsules (both Beta-Lactam and non-Beta-Lactam), as well as oral rehydration solutions (ORS). Its manufacturing operations are based in the GIDC industrial estate at Bavla, near Ahmedabad.
The company distributes its products throughout India and also exports to various international regions such as Africa, the Middle East, and CIS countries. JFL Life Sciences emphasizes high-quality manufacturing practices supported by research and development initiatives and advanced production infrastructure to address growing global healthcare needs.
